Retractable Technologies CEO buys $25,626 in company stock

Investors in Retractable Technologies Inc (NYSEAMERICAN:RVP) may take note as Thomas J. Shaw, the company's President and CEO, has recently purchased shares valued at a total of $25,626. The transactions, which occurred on September 18 and 19, 2024, involved Shaw acquiring a combined total of 28,890 shares at weighted average prices ranging from $0.8869 to $0.8905.

Retractable Technologies, known for its medical and surgical instruments, saw its CEO increase his direct holdings in the company significantly through these purchases. On the first day, Shaw purchased 1,180 shares, and on the following day, he added another 27,710 shares to his portfolio. Following these transactions, Shaw's direct ownership in the company stands at 14,672,485 shares.

The recent stock purchases by Shaw are part of a Rule 10b5-1 trading plan, which was adopted on August 22, 2023. This plan allows company insiders to establish predetermined trading arrangements for buying or selling stock and is typically used to avoid accusations of insider trading.

Additionally, Shaw has indirect control over 831,600 shares, with investment power over 500,000 of those as a trustee for a family member. The remaining shares are under his voting control according to a voting agreement, as detailed in the footnotes of the SEC filing.

Retractable Technologies has not made any further comments regarding these transactions, and the purchases appear to be a straightforward increase in Shaw's stake in the company he leads. Shareholders and potential investors often look to insider buying as a sign of confidence in the company's future prospects.InvestingPro Insights


As Thomas J. Shaw, President and CEO of Retractable Technologies Inc (NYSEAMERICAN:RVP), demonstrates confidence in the company by purchasing additional shares, investors may be interested in the latest financial data and expert analysis to further understand the company's current standing. According to InvestingPro, Retractable Technologies has faced some financial challenges, as indicated by a significant revenue decline over the last twelve months leading up to Q2 2024, with a drop of 30.08%. This decline is also reflected in their quarterly revenue growth, which decreased by 24.36%.

Despite the revenue downturn, the company maintains a gross profit margin of 19.19%, with a gross profit of $7.34M USD during the same period. However, the operating income has been negative, at -12.46M USD, resulting in an operating income margin of -32.58%. This suggests that while the company is able to generate a gross profit, it is currently facing challenges in managing its operating expenses.

InvestingPro Tips highlight that Retractable Technologies operates with a moderate level of debt and has liquid assets that exceed short-term obligations, which may provide some financial stability in the face of these revenue and profit challenges. However, it's also noted that the company has not been profitable over the last twelve months and does not pay a dividend to shareholders, which could be a concern for those looking for income-generating investments.

With stock price movements described as quite volatile, investors may want to stay updated on market trends and company performance. The InvestingPro platform offers a comprehensive set of additional tips for Retractable Technologies, which can be accessed to gain a more in-depth understanding of the company's financial health and stock performance. As of now, there are four additional InvestingPro Tips available for investors seeking further guidance.

For those considering an investment in Retractable Technologies, these insights could prove invaluable in making informed decisions. The next earnings date is set for November 12, 2024, which will likely provide further clarity on the company's trajectory and potentially impact the stock's performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Source: Investing.com

Последние публикации
US stocks mixed as investors weigh FedEx slump, Fed outlook
20.09.2024 - 21:00
Kayne Anderson BDC director Schnabel buys $7.6k in shares
20.09.2024 - 21:00
US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
20.09.2024 - 21:00
Murdoch-backed REA sweetens offer for UK's Rightmove to nearly $7.9 billion, FT reports
20.09.2024 - 21:00
US Fed's relaxed bank capital plan faces pushback from regulator, sources say
20.09.2024 - 21:00
US House votes to repeal Biden administration tailpipe emissions rules
20.09.2024 - 21:00
CAMP4 Therapeutics Files for Proposed IPO
20.09.2024 - 21:00
Germany to hold onto Commerzbank stake as lender aims for independence
20.09.2024 - 21:00
FedEx shares tumble 16% on limp demand, delivery trade-down
20.09.2024 - 21:00
Finland stocks lower at close of trade; OMX Helsinki 25 down 1.12%
20.09.2024 - 20:00
France stocks mixed at close of trade; CAC 40 down 1.51%
20.09.2024 - 20:00
Belgium stocks lower at close of trade; BEL 20 down 0.98%
20.09.2024 - 20:00
Bullish sentiment surges among retail investors post Fed cut
20.09.2024 - 20:00
Germany stocks lower at close of trade; DAX down 1.43%
20.09.2024 - 20:00
Powerschool holdings CPO sells over $64k in stock
20.09.2024 - 20:00

© Analytic DC. All Rights Reserved.

new
Анализ трейдера Анализ трейдера за 20.09.24
Добро пожаловать в чат поддержки!
*
*

Ваш запрос успешно отправлен!
Скоро с вами свяжутся.